カテゴリ： 世界, 医療/バイオ, QYResearch

レアNGR1フュージョンの世界市場2023年：免疫療法、化学療法、放射線療法

■ 英語タイトル：Global Rare NGR1 Fusion Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8312）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8312
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[レアNGR1フュージョンの世界市場2023年：免疫療法、化学療法、放射線療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はレアNGR1フュージョンのグローバル市場について調査・分析し、世界のレアNGR1フュージョン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（免疫療法、化学療法、放射線療法）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Elevation Oncology、Merus、Hummingbird Bioscience、Boehringer Ingelheim、CANbridge Pharmaceuticals、Salubris Biotherapeutics、AVEO Oncology、Rain Therapeutics、Eli Lilly and Company、Jiangsu Hengrui Medicineなどが含まれています。レアNGR1フュージョンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、レアNGR1フュージョン市場規模を算出する際に考慮しました。

・レアNGR1フュージョン市場の概要
- レアNGR1フュージョンの種類別セグメント
- 世界のレアNGR1フュージョン市場規模：タイプ別分析（免疫療法、化学療法、放射線療法）
- レアNGR1フュージョンの用途別セグメント
- 世界のレアNGR1フュージョン市場規模：用途別分析（病院、クリニック、その他）
- 世界のレアNGR1フュージョン市場規模予測（2018年-2029年）

・レアNGR1フュージョン市場の成長トレンド
- レアNGR1フュージョンの地域別市場規模（2018年-2029年）
- レアNGR1フュージョン市場ダイナミクス
- レアNGR1フュージョンの業界動向
- レアNGR1フュージョン市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：免疫療法、化学療法、放射線療法
- 世界のレアNGR1フュージョンのタイプ別市場規模（2018年-2023年）
- 世界のレアNGR1フュージョンのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界のレアNGR1フュージョンの用途別市場規模（2018年-2023年）
- 世界のレアNGR1フュージョンの用途別市場規模（2024年-2029年）

・レアNGR1フュージョンの地域別市場規模
- 北米のレアNGR1フュージョン市場規模（2018年-2029年）
- 米国のレアNGR1フュージョン市場規模（2018年-2029年）
- ヨーロッパのレアNGR1フュージョン市場規模（2018年-2029年）
- アジア太平洋のレアNGR1フュージョン市場規模（2018年-2029年）
- 中国のレアNGR1フュージョン市場規模（2018年-2029年）
- 日本のレアNGR1フュージョン市場規模（2018年-2029年）
- 韓国のレアNGR1フュージョン市場規模（2018年-2029年）
- インドのレアNGR1フュージョン市場規模（2018年-2029年）
- オーストラリアのレアNGR1フュージョン市場規模（2018年-2029年）
- 中南米のレアNGR1フュージョン市場規模（2018年-2029年）
- 中東・アフリカのレアNGR1フュージョン市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Elevation Oncology、Merus、Hummingbird Bioscience、Boehringer Ingelheim、CANbridge Pharmaceuticals、Salubris Biotherapeutics、AVEO Oncology、Rain Therapeutics、Eli Lilly and Company、Jiangsu Hengrui Medicine

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Rare NGR1 Fusion market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Rare NGR1 Fusion is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rare NGR1 Fusion is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Rare NGR1 Fusion in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Rare NGR1 Fusion include Elevation Oncology, Merus, Hummingbird Bioscience, Boehringer Ingelheim, CANbridge Pharmaceuticals, Salubris Biotherapeutics, AVEO Oncology, Rain Therapeutics and Eli Lilly and Company, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rare NGR1 Fusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare NGR1 Fusion.
The Rare NGR1 Fusion market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rare NGR1 Fusion market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare NGR1 Fusion companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Elevation Oncology
Merus
Hummingbird Bioscience
Boehringer Ingelheim
CANbridge Pharmaceuticals
Salubris Biotherapeutics
AVEO Oncology
Rain Therapeutics
Eli Lilly and Company
Jiangsu Hengrui Medicine
Segment by Type
Immunotherapy
Chemotherapy
Radiation Therapy
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare NGR1 Fusion companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare NGR1 Fusion Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.3 Market by Application
1.3.1 Global Rare NGR1 Fusion Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare NGR1 Fusion Market Perspective (2018-2029)
2.2 Rare NGR1 Fusion Growth Trends by Region
2.2.1 Global Rare NGR1 Fusion Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rare NGR1 Fusion Historic Market Size by Region (2018-2023)
2.2.3 Rare NGR1 Fusion Forecasted Market Size by Region (2024-2029)
2.3 Rare NGR1 Fusion Market Dynamics
2.3.1 Rare NGR1 Fusion Industry Trends
2.3.2 Rare NGR1 Fusion Market Drivers
2.3.3 Rare NGR1 Fusion Market Challenges
2.3.4 Rare NGR1 Fusion Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare NGR1 Fusion Players by Revenue
3.1.1 Global Top Rare NGR1 Fusion Players by Revenue (2018-2023)
3.1.2 Global Rare NGR1 Fusion Revenue Market Share by Players (2018-2023)
3.2 Global Rare NGR1 Fusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare NGR1 Fusion Revenue
3.4 Global Rare NGR1 Fusion Market Concentration Ratio
3.4.1 Global Rare NGR1 Fusion Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare NGR1 Fusion Revenue in 2022
3.5 Rare NGR1 Fusion Key Players Head office and Area Served
3.6 Key Players Rare NGR1 Fusion Product Solution and Service
3.7 Date of Enter into Rare NGR1 Fusion Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare NGR1 Fusion Breakdown Data by Type
4.1 Global Rare NGR1 Fusion Historic Market Size by Type (2018-2023)
4.2 Global Rare NGR1 Fusion Forecasted Market Size by Type (2024-2029)
5 Rare NGR1 Fusion Breakdown Data by Application
5.1 Global Rare NGR1 Fusion Historic Market Size by Application (2018-2023)
5.2 Global Rare NGR1 Fusion Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rare NGR1 Fusion Market Size (2018-2029)
6.2 North America Rare NGR1 Fusion Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rare NGR1 Fusion Market Size by Country (2018-2023)
6.4 North America Rare NGR1 Fusion Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare NGR1 Fusion Market Size (2018-2029)
7.2 Europe Rare NGR1 Fusion Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rare NGR1 Fusion Market Size by Country (2018-2023)
7.4 Europe Rare NGR1 Fusion Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare NGR1 Fusion Market Size (2018-2029)
8.2 Asia-Pacific Rare NGR1 Fusion Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rare NGR1 Fusion Market Size by Region (2018-2023)
8.4 Asia-Pacific Rare NGR1 Fusion Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare NGR1 Fusion Market Size (2018-2029)
9.2 Latin America Rare NGR1 Fusion Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rare NGR1 Fusion Market Size by Country (2018-2023)
9.4 Latin America Rare NGR1 Fusion Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare NGR1 Fusion Market Size (2018-2029)
10.2 Middle East & Africa Rare NGR1 Fusion Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rare NGR1 Fusion Market Size by Country (2018-2023)
10.4 Middle East & Africa Rare NGR1 Fusion Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elevation Oncology
11.1.1 Elevation Oncology Company Detail
11.1.2 Elevation Oncology Business Overview
11.1.3 Elevation Oncology Rare NGR1 Fusion Introduction
11.1.4 Elevation Oncology Revenue in Rare NGR1 Fusion Business (2018-2023)
11.1.5 Elevation Oncology Recent Development
11.2 Merus
11.2.1 Merus Company Detail
11.2.2 Merus Business Overview
11.2.3 Merus Rare NGR1 Fusion Introduction
11.2.4 Merus Revenue in Rare NGR1 Fusion Business (2018-2023)
11.2.5 Merus Recent Development
11.3 Hummingbird Bioscience
11.3.1 Hummingbird Bioscience Company Detail
11.3.2 Hummingbird Bioscience Business Overview
11.3.3 Hummingbird Bioscience Rare NGR1 Fusion Introduction
11.3.4 Hummingbird Bioscience Revenue in Rare NGR1 Fusion Business (2018-2023)
11.3.5 Hummingbird Bioscience Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Rare NGR1 Fusion Introduction
11.4.4 Boehringer Ingelheim Revenue in Rare NGR1 Fusion Business (2018-2023)
11.4.5 Boehringer Ingelheim Recent Development
11.5 CANbridge Pharmaceuticals
11.5.1 CANbridge Pharmaceuticals Company Detail
11.5.2 CANbridge Pharmaceuticals Business Overview
11.5.3 CANbridge Pharmaceuticals Rare NGR1 Fusion Introduction
11.5.4 CANbridge Pharmaceuticals Revenue in Rare NGR1 Fusion Business (2018-2023)
11.5.5 CANbridge Pharmaceuticals Recent Development
11.6 Salubris Biotherapeutics
11.6.1 Salubris Biotherapeutics Company Detail
11.6.2 Salubris Biotherapeutics Business Overview
11.6.3 Salubris Biotherapeutics Rare NGR1 Fusion Introduction
11.6.4 Salubris Biotherapeutics Revenue in Rare NGR1 Fusion Business (2018-2023)
11.6.5 Salubris Biotherapeutics Recent Development
11.7 AVEO Oncology
11.7.1 AVEO Oncology Company Detail
11.7.2 AVEO Oncology Business Overview
11.7.3 AVEO Oncology Rare NGR1 Fusion Introduction
11.7.4 AVEO Oncology Revenue in Rare NGR1 Fusion Business (2018-2023)
11.7.5 AVEO Oncology Recent Development
11.8 Rain Therapeutics
11.8.1 Rain Therapeutics Company Detail
11.8.2 Rain Therapeutics Business Overview
11.8.3 Rain Therapeutics Rare NGR1 Fusion Introduction
11.8.4 Rain Therapeutics Revenue in Rare NGR1 Fusion Business (2018-2023)
11.8.5 Rain Therapeutics Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Rare NGR1 Fusion Introduction
11.9.4 Eli Lilly and Company Revenue in Rare NGR1 Fusion Business (2018-2023)
11.9.5 Eli Lilly and Company Recent Development
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Detail
11.10.2 Jiangsu Hengrui Medicine Business Overview
11.10.3 Jiangsu Hengrui Medicine Rare NGR1 Fusion Introduction
11.10.4 Jiangsu Hengrui Medicine Revenue in Rare NGR1 Fusion Business (2018-2023)
11.10.5 Jiangsu Hengrui Medicine Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rare NGR1 Fusion Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Global Rare NGR1 Fusion Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Rare NGR1 Fusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Rare NGR1 Fusion Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Rare NGR1 Fusion Market Share by Region (2018-2023)
Table 9. Global Rare NGR1 Fusion Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Rare NGR1 Fusion Market Share by Region (2024-2029)
Table 11. Rare NGR1 Fusion Market Trends
Table 12. Rare NGR1 Fusion Market Drivers
Table 13. Rare NGR1 Fusion Market Challenges
Table 14. Rare NGR1 Fusion Market Restraints
Table 15. Global Rare NGR1 Fusion Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Rare NGR1 Fusion Market Share by Players (2018-2023)
Table 17. Global Top Rare NGR1 Fusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare NGR1 Fusion as of 2022)
Table 18. Ranking of Global Top Rare NGR1 Fusion Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Rare NGR1 Fusion Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rare NGR1 Fusion Product Solution and Service
Table 22. Date of Enter into Rare NGR1 Fusion Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare NGR1 Fusion Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Rare NGR1 Fusion Revenue Market Share by Type (2018-2023)
Table 26. Global Rare NGR1 Fusion Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Rare NGR1 Fusion Revenue Market Share by Type (2024-2029)
Table 28. Global Rare NGR1 Fusion Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Rare NGR1 Fusion Revenue Market Share by Application (2018-2023)
Table 30. Global Rare NGR1 Fusion Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Rare NGR1 Fusion Revenue Market Share by Application (2024-2029)
Table 32. North America Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Rare NGR1 Fusion Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Rare NGR1 Fusion Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Rare NGR1 Fusion Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Rare NGR1 Fusion Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Rare NGR1 Fusion Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Rare NGR1 Fusion Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Rare NGR1 Fusion Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Rare NGR1 Fusion Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Rare NGR1 Fusion Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Rare NGR1 Fusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Rare NGR1 Fusion Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Rare NGR1 Fusion Market Size by Country (2024-2029) & (US$ Million)
Table 47. Elevation Oncology Company Detail
Table 48. Elevation Oncology Business Overview
Table 49. Elevation Oncology Rare NGR1 Fusion Product
Table 50. Elevation Oncology Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 51. Elevation Oncology Recent Development
Table 52. Merus Company Detail
Table 53. Merus Business Overview
Table 54. Merus Rare NGR1 Fusion Product
Table 55. Merus Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 56. Merus Recent Development
Table 57. Hummingbird Bioscience Company Detail
Table 58. Hummingbird Bioscience Business Overview
Table 59. Hummingbird Bioscience Rare NGR1 Fusion Product
Table 60. Hummingbird Bioscience Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 61. Hummingbird Bioscience Recent Development
Table 62. Boehringer Ingelheim Company Detail
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Rare NGR1 Fusion Product
Table 65. Boehringer Ingelheim Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. CANbridge Pharmaceuticals Company Detail
Table 68. CANbridge Pharmaceuticals Business Overview
Table 69. CANbridge Pharmaceuticals Rare NGR1 Fusion Product
Table 70. CANbridge Pharmaceuticals Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 71. CANbridge Pharmaceuticals Recent Development
Table 72. Salubris Biotherapeutics Company Detail
Table 73. Salubris Biotherapeutics Business Overview
Table 74. Salubris Biotherapeutics Rare NGR1 Fusion Product
Table 75. Salubris Biotherapeutics Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 76. Salubris Biotherapeutics Recent Development
Table 77. AVEO Oncology Company Detail
Table 78. AVEO Oncology Business Overview
Table 79. AVEO Oncology Rare NGR1 Fusion Product
Table 80. AVEO Oncology Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 81. AVEO Oncology Recent Development
Table 82. Rain Therapeutics Company Detail
Table 83. Rain Therapeutics Business Overview
Table 84. Rain Therapeutics Rare NGR1 Fusion Product
Table 85. Rain Therapeutics Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 86. Rain Therapeutics Recent Development
Table 87. Eli Lilly and Company Company Detail
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Rare NGR1 Fusion Product
Table 90. Eli Lilly and Company Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 91. Eli Lilly and Company Recent Development
Table 92. Jiangsu Hengrui Medicine Company Detail
Table 93. Jiangsu Hengrui Medicine Business Overview
Table 94. Jiangsu Hengrui Medicine Rare NGR1 Fusion Product
Table 95. Jiangsu Hengrui Medicine Revenue in Rare NGR1 Fusion Business (2018-2023) & (US$ Million)
Table 96. Jiangsu Hengrui Medicine Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare NGR1 Fusion Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Rare NGR1 Fusion Market Share by Type: 2022 VS 2029
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Rare NGR1 Fusion Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Rare NGR1 Fusion Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Rare NGR1 Fusion Report Years Considered
Figure 12. Global Rare NGR1 Fusion Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Rare NGR1 Fusion Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Rare NGR1 Fusion Market Share by Region: 2022 VS 2029
Figure 15. Global Rare NGR1 Fusion Market Share by Players in 2022
Figure 16. Global Top Rare NGR1 Fusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare NGR1 Fusion as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Rare NGR1 Fusion Revenue in 2022
Figure 18. North America Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Rare NGR1 Fusion Market Share by Country (2018-2029)
Figure 20. United States Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Rare NGR1 Fusion Market Share by Country (2018-2029)
Figure 24. Germany Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Rare NGR1 Fusion Market Share by Region (2018-2029)
Figure 32. China Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Rare NGR1 Fusion Market Share by Country (2018-2029)
Figure 40. Mexico Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Rare NGR1 Fusion Market Share by Country (2018-2029)
Figure 44. Turkey Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Rare NGR1 Fusion Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Elevation Oncology Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 47. Merus Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 48. Hummingbird Bioscience Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 50. CANbridge Pharmaceuticals Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 51. Salubris Biotherapeutics Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 52. AVEO Oncology Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 53. Rain Therapeutics Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 55. Jiangsu Hengrui Medicine Revenue Growth Rate in Rare NGR1 Fusion Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍薬の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • 皮膚T細胞リンパ腫の世界市場2023年：放射線治療、幹細胞移植、局所化学療法、化学療法、免疫療法
  • 血液腫瘍薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、その他
  • ホルモン放出アゴニストのグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • 腱滑膜巨細胞腫治療の世界市場2023年：薬物療法、放射線療法、外科手術
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8312 )"レアNGR1フュージョンの世界市場2023年：免疫療法、化学療法、放射線療法" (英文：Global Rare NGR1 Fusion Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。